These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7297020)

  • 21. Effects of the R(+)- and S(-)-isomers of beta-adrenoceptor blockers with intrinsic sympathomimetic activity, befunolol and carteolol, on rabbit intraocular pressure.
    Takayanagi I; Hagiwara H; Koike K; Hosokawa T; Kasuya Y
    Can J Physiol Pharmacol; 1991 Aug; 69(8):1243-5. PubMed ID: 1685941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats.
    Igawa T; Ikezono K; Watanabe K; Kimura Y
    Eur J Pharmacol; 1984 Sep; 104(1-2):93-9. PubMed ID: 6238834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
    Ishizaki T; Ohnishi A; Sasaki T; Kushida K; Horai Y; Chiba K; Suganuma T
    Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of topical carteolol on the normal human retinal circulation.
    Grunwald JE; Delehanty J
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1853-6. PubMed ID: 1582788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline].
    Le Jeunne C; Munera Y; Teillet L; Hugues FC
    Allerg Immunol (Paris); 1988 Sep; 20(7):267-9. PubMed ID: 2902862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
    Frishman WH; Covey S
    J Clin Pharmacol; 1990 May; 30(5):412-21. PubMed ID: 2189902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension.
    Shimada K; Kawamoto A; Matsubayashi K; Chikamori T; Kuzume O; Ozawa T
    Clin Ther; 1990; 12(2):118-24. PubMed ID: 1972351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol.
    Gwathmey JK; Kim CS; Hajjar RJ; Khan F; DiSalvo TG; Matsumori A; Bristow MR
    Am J Physiol; 1999 May; 276(5):H1678-90. PubMed ID: 10330254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentration-heart rate response relationship.
    Ohnishi A; Minegishi A; Ishizaki T
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):667-74. PubMed ID: 2450237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
    Giles TD; Sander GE; Roffidal L; Thomas MG; Mersch DP; Moyer RR; Burris JF; Mroczek WJ; Brachfeld J
    Arch Intern Med; 1988 Aug; 148(8):1725-8. PubMed ID: 3041936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of carteolol on renal function in healthy subjects and patients with hypertension.
    Tabei K; Furuya H; Asano Y; Hosoda S
    Eur J Clin Pharmacol; 1989; 36(1):83-6. PubMed ID: 2917595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
    Le Jeunne C; Munera Y; Hugues FC
    Clin Pharmacol Ther; 1990 May; 47(5):578-83. PubMed ID: 1971539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
    J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An examination of the hemodynamic and metabolic effects of carteolol during different workloads on a bicycle ergometer.
    Krümke W; Mader A; Michael H; Giannetti BM; Hollmann W
    Int J Sports Med; 1991 Dec; 12(6):548-56. PubMed ID: 1797696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke-prone spontaneously hypertensive rats.
    Yamashita K; Ohta H; Uchida S; Shigematsu K; Ohkubo T; Niwa M; Ozaki M
    J Pharmacobiodyn; 1990 Jan; 13(1):64-9. PubMed ID: 1971305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
    Saxenhofer H; Morger D; Weidmann P; Ferrier C; Shaw SG
    J Hypertens; 1991 Nov; 9(11):1049-56. PubMed ID: 1661763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
    Luther RR; Glassman HN; Jordan DC; Klepper MJ
    J Int Med Res; 1986; 14(4):167-74. PubMed ID: 3093295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.